{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:53:39Z","timestamp":1791194019640,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.jneuroim.2003.10.016","type":"journal-article","created":{"date-parts":[[2004,1,20]],"date-time":"2004-01-20T05:18:45Z","timestamp":1074575925000},"page":"78-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet"],"prefix":"10.1016","volume":"147","author":[{"given":"Sabita","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumandeep","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Charboneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horace H.","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick A.","family":"Barke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2003.10.016_BIB1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0952-7915(99)00051-5","article-title":"The role of IL-18 in innate immunity","volume":"12","author":"Akira","year":"2000","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/MCB.17.1.199","article-title":"Memory and effector, but not naive T cells, express transcriptional activity under the control of two IFN (promoter elements","volume":"17","author":"Aune","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB3","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archinte.1974.00320240035003","article-title":"Immunological dysfunction in heroin addicts","volume":"134","author":"Brown","year":"1974","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB4","first-page":"563","article-title":"Molecular basis of T-cell differentiation","volume":"vol. LXIV","author":"Flavell","year":"1999"},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.immunol.17.1.149","article-title":"Transcriptional regulation of T-lymphocyte development and function","volume":"17","author":"Kuo","year":"1999","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2003.10.016_BIB6","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.4049\/jimmunol.161.3.1380","article-title":"Th2-specific protein\/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter","volume":"161","author":"Li-Weber","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/clinids\/8.3.374","article-title":"Bacteremia in narcotic addicts at the Detroit Medical Center","volume":"8","author":"Levine","year":"1986","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB8","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/00126334-200210012-00008","article-title":"Does reduced DNA repair capacity play a role in HIV infection and progression in the lymphocytes of opiate addicts","volume":"31","author":"Madden","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0376-8716(00)00181-2","article-title":"Opioids, opioid receptors and the immune response","volume":"62","author":"McCarthy","year":"2001","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"Th1 and Th2 cells. Different patterns of lymphokine secretion","volume":"7","author":"Mossman","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-3083.1998-47-1.00383.x","article-title":"Revisiting the Th1\/Th2 paradigm","volume":"47","author":"Muraille","year":"1998","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.18.1.451","article-title":"Signaling and transcription in T-helper development","volume":"18","author":"Murphy","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB12","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1084\/jem.178.5.1483","article-title":"Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells","volume":"178","author":"Penix","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB13","doi-asserted-by":"crossref","first-page":"31964","DOI":"10.1074\/jbc.271.50.31964","article-title":"The proximal regulatory element of the interferon-promoter mediates selective expression in T cells","volume":"271","author":"Penix","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB14","first-page":"1","article-title":"Targeting the brain's immune system","volume":"493","author":"Peterson","year":"2001","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.jneuroim.2003.10.016_BIB15","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.4049\/jimmunol.161.8.3822","article-title":"GATA-3-dependent enhancer activity in IL-4 gene regulation","volume":"161","author":"Ranganath","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB16","first-page":"503","volume":"47","author":"Rouviex","year":"1992","journal-title":"Opiates Immune Funct. Ther."},{"issue":"11","key":"10.1016\/j.jneuroim.2003.10.016_BIB17","first-page":"1373","volume":"21","author":"Roy","year":"1996","journal-title":"Effects of opioids on the immune system neurochemical research"},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-5728(98)00265-3","article-title":"Morphine synergizes with LPS in an experimental sepsis model","volume":"95","author":"Roy","year":"1999","journal-title":"J.Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2003.10.016_BIB19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1067\/msy.2001.116033","article-title":"Morphine directs T cells toward Th2 differentiation","volume":"130","author":"Roy","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB26","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2249.1998.00680.x","article-title":"Endogenous opiods modulate allgraft rejection time in mice: Possible relation with Th1\/Th2 cytokines","volume":"113","author":"Sacerdote","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1749-6632.2000.tb05440.x","article-title":"The opioid antagonist naloxone induces a shift from type 2 to type 2 cytokine pattern in normal and skin grafted mice","volume":"917","author":"Sacerdote","year":"2000","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1182\/blood.V95.6.2031","article-title":"The opioid antagonist naloxone induces a shift from type 2 to type 1 cytokine pattern in Balb\/cJ mice","volume":"95","author":"Sacerdote","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(02)00370-3","volume":"133","author":"Yuan","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2003.10.016_BIB24","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.4049\/jimmunol.161.11.6105","article-title":"Regulation of the activity of IFN-( promoter elements during Th cell differentiation","volume":"161","author":"Zhang","year":"1998","journal-title":"J. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572803004351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572803004351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:58:37Z","timestamp":1759046317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572803004351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":26,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0165572803004351"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2003.10.016","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2003.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}